The company is a high-tech enterprise specializing in the research and development, production and sales of monomer vitamins. With the purpose of "strengthening the enterprise, achieving employees, serving the society and healthy human beings", the company is committed to providing solutions for global customers in the field of human health and animal nutrition. In terms of domestic sales, the company has sales in various provinces in China; in terms of export, it is mainly sold in Europe, America, Asia and other countries and regions. The company's products are divided into B vitamins, other vitamins, fine chemicals and other three major business sectors.

The company has and is under construction capacity and projects. 1) the company has a production capacity of 6500 tons of vitamin B6, 4000 tons of vitamin B1 and 90 tons of biotin. 2) the company has built new vitamin A, vitamin B5, cholesterol and 25-hydroxyvitamin D3 projects, including annual production of 1000 tons of vitamin A, annual production of 7000 tons of vitamin B5 and annual production of 350tons of cholesterol and 6 tons of 25-hydroxyvitamin D3. 3) according to the company announcement, the company plans to invest 610 million yuan to build fine chemicals projects such as GBL and tocopherol acetate, and plans to invest 280 million yuan to build cogeneration projects.

The company has leading technology and R & D advantages. 1) the company is committed to the research, development, production and sales of monomer vitamins, and has a strong core competitiveness in the field of vitamins. At present, it has established and formed vitamin B6, vitamin B1, biotin, folic acid, vitamin D3, ascorbate palmitate, vitamin E powder and other multi-product matrix to provide supporting services for customers in the global feed, pharmaceutical, food and other industries. With years of technical accumulation in the field of vitamins, continuous market development and excellent product quality, the company's products are widely recognized by customers and have a high market reputation and brand influence. 3) the company is one of the important suppliers in the global B vitamin market and occupies a high market share in many B vitamin products. According to Boya and Xun statistics, the company leads the world in the market share of vitamin B6 and vitamin B1 products, and the market share of biotin and folic acid products is in the first echelon of the industry. 4) the company steadily promotes the development process of reserve products, and the pilot test work of vitamin B5, vitamin A, cholesterol and 25-hydroxyvitamin D3 has been carried out smoothly and gradually improved, and will enter the stage of large-scale production design and construction in the future.

The company will rely on advanced production technology, complete manufacturing system, comprehensive quality management, scientific construction of vitamin product matrix, enhance the company's market competitiveness in the vitamin industry. 1) in terms of existing products, the company will continue to consolidate the dominant position of vitamin B6, vitamin B1, biotin, folic acid and other products, and continue to enhance the market share of other vitamins, ABL and other products. 2) in the aspect of new product development, the company will horizontally expand the varieties of vitamin A, vitamin B5, 25-hydroxyvitamin D3, tocopherol acetate and so on, so as to enhance the ability of customer service and coverage in an all-round way. to become a domestic benchmark and an international first-class vitamin manufacturer.

Risk hint: the prices of raw materials and products fluctuate greatly, and the progress of project construction and production is not as expected.